VSTM FY 2023 Earnings — Verastem, Inc. Revenue & Financial Results | Market Cap Arena

VSTMVerastem, Inc.

$388M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$92M

Net Income

-$87M

EPS (Diluted)

$-3.96

Cash Flow

Operating Cash Flow

-$86M

Free Cash Flow

-$86M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$150M

Total Liabilities

$92M

Stockholders' Equity

$57M

Cash & Equivalents

$78M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$3M	-100.0%
Gross Profit	$0	$3M	-100.0%
Operating Income	-$92M	-$73M	-26.3%
Net Income	-$87M	-$74M	-18.4%